Subject wise Global Events

Liposomes as injectable drug carriers have been extensively investigated due to their biocompatibility and effective drug encapsulating property. However, liposomes that are administered through intravenous injection are rapidly uptaken by reticuloendothelial system (RES) cells in the liver and spleen. Therefore, techniques based on surface modification have been developed for preventing the uptake by RES cells in order to increase the liposomes effectiveness.